.svg){kind=small}
Jul-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Where to Buy
Phas3 is stocked at 61 licensed dispensaries across Maryland, with the deepest coverage in Baltimore, Annapolis, Silver Spring, Brandywine, and Cockeysville. Search by ZIP code or city below to find the closest one, or filter by product type if you are after a specific format.
Market Insights Snapshot
Phas3’s July 2026 category mix concentrated sharply into Flower at 75.69% share with 230.16% year-over-year growth and 59.02% month-over-month lift, while Pre-Roll contracted to 14.85% share on a -17.36% YoY decline and -18.38% MoM drop. Smaller lines swung widely: Concentrates climbed to 5.23% share with 768.20% YoY and 401.31% MoM growth, and Vapor Pens reached 4.23% share with 92.58% YoY and 36.72% MoM gains. With brand-level sales up 128.89% YoY and average price up 34.69%, the pattern implies a pivot toward higher-ticket Flower (average price $29.74) as the primary growth engine, while retreat in Pre-Roll reallocates volume toward higher-margin or newly scaled formats.
Positioning-wise, a 59.02% MoM surge in Flower alongside a -18.38% MoM pullback in Pre-Roll suggests deliberate shelf strategy favoring premiumizable Flower over lower-priced units, reinforced by a 401.31% MoM spike in Concentrates that diversifies potency-led offerings. Given a rank of 27 in Flower in Maryland and 92.58% YoY growth in Vapor Pens, the brand is building a two-pronged stance—Flower as scale anchor and concentrates/vapes as momentum flank—which implies future promotions should protect Flower price architecture while using fast-growing concentrates to open new baskets.
Competitive Landscape
Phas3 is currently ranked #27 in MD Flower in July 2026, improving 13 positions from #40 year over year, and edging up 3 spots from #30 in April 2026 to reach a new peak rank of #27 in July 2026; meanwhile, category leaders held or strengthened positions, with SunMed steady at #1 year over year while growing sales 7.8%, and RYTHM advancing from #3 to #2 alongside a 47.9% sales increase, indicating that Phas3’s upward rank change is occurring against competitors that are consolidating at the top. The juxtaposition of Phas3’s 13-rank YoY climb with Fade Co. sliding from #2 to #3 despite 12.7% sales growth, and Strane jumping from #8 to #5 on 82.3% sales growth, implies that Phas3’s trajectory is consistent but will require further share capture to translate mid-pack gains into top-tier contention.
Notable Products
AK-47 (3.5g) posted the largest Month-over-Month movement in July 2026 with a 140.36% surge, climbing into rank 2, while Green Crack (3.5g) fell 16.48% at rank 8, marking the steepest decline; across the leaderboard, Pineapple Express (3.5g) rose 63.01% to rank 1 and Lemon Skunk Pre-Roll 2-Pack (1g) slid 14.32% to rank 5. Four of the top ten are Flower SKUs, and two of the top five are Pre-Roll SKUs, indicating a portfolio tilt anchored by Flower velocity even as Pre-Rolls show mixed momentum; with Pineapple Express (3.5g) generating $55,851 alongside AK-47 (3.5g)’s outsized gain, the pattern implies a strategy concentrating demand into a few high-velocity Flower strains while pruning underperforming Pre-Rolls.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
